Efficacy of Dose Escalation of Oral 5-Aminosalicylic Acid for Ulcerative Colitis With a Mayo Endoscopic Subscore of 1: An Open Label Randomized Controlled Trial.

Tomohiro FukudaYasuhiro AokiHiroki KiyoharaAyumi YokoyamaAtsushi NakazawaYusuke YoshimatsuShinya SugimotoKosaku NankiYohei MikamiKayoko FukuharaShinta MizunoTomohisa SujinoMakoto MutaguchiKaoru TakabayashiYuichi MorohoshiYasuo HosodaHaruhiko OgataYasushi IwaoMakoto NaganumaTakanori Kanai

Published in: Inflammatory bowel diseases (2024)

Dose escalation of 5-ASA reduced relapse within 1 year in UC patients in clinical remission with an MES of 1.

Keyphrases

ulcerative colitis
randomized controlled trial
end stage renal disease
ejection fraction
newly diagnosed
open label
study protocol
peritoneal dialysis
prognostic factors
systematic review
systemic lupus erythematosus
patient reported outcomes